Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopaminergic neuron survival pathway encompasses a network of molecular signals and cellular mechanisms that promote the maintenance, protection, and longevity of dopaminergic neurons—cells primarily responsible for producing dopamine in the brain. These pathways are crucial for normal motor function, reward processing, and are particularly relevant to neurodegenerative diseases such as Parkinson’s disease (PD), where selective loss of these neurons is a hallmark feature. Key components include the Unfolded Protein Response (UPR) mediated by XBP1, Wnt/β-catenin and Sonic Hedgehog (Shh) pathways, Extracellular Matrix Signaling through the Laminin-511/YAP axis, and Dopamine Metabolism & Detoxification. Disruption or failure within any component increases susceptibility to neurodegeneration. Therapeutic strategies targeting these pathways aim at slowing progression or restoring lost neuronal populations through gene therapy or small molecules modulating key nodes.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopaminergic Neuron Survival Pathway (N/A).